Blog | Page 207 of 2077 | Real Peptides®

Does SS-31 Cause Side Effects in Studies? Research Data

SS-31 demonstrates minimal adverse events in clinical trials, with fatigue and headache reported in under 5% of participants. Mitochondrial peptides show

How Long Is SS-31 Stable Once Reconstituted? (Storage Rules)

SS-31 remains stable for 28 days refrigerated after reconstitution with bacteriostatic water. Temperature excursions above 8°C cause irreversible peptide

What’s the Half-Life of SS-31? (Elamipretide Timing)

SS-31 (elamipretide) has a plasma half-life of 30–60 minutes, requiring specific dosing schedules to maintain therapeutic mitochondrial protection

SS-31 vs Elamipretide — What’s the Real Difference?

SS-31 and elamipretide are the same peptide with identical mechanisms — the name changed during clinical trials. Here’s what researchers need to know

Is SS-31 Legal to Purchase for Research? (2026 Rules)

SS-31 is legal to purchase for research in 2026 under strict FDA compliance. Learn compound sourcing rules, 503B facility standards, and documentation

SS-31 vs Research Peptides — Mitochondrial Targets Compared

SS-31 selectively targets mitochondrial membranes — a mechanism most research peptides lack. Learn how cardiolipin binding separates it from BPC-157,

What Does SS-31 Look Like in Solution? (Visual Guide)

SS-31 solution appears as a clear, colorless to slightly yellowish liquid when properly reconstituted. Cloudiness, particles, or color changes signal

How Concentrated Should SS-31 Be for Research? (Dosing

SS-31 concentration typically ranges from 0.1 to 10 mg/mL for cellular studies, with 1-5 mg/mL most common. Optimal concentration depends on your study